Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
8
×
clinical trials
8
×
life sciences
national blog main
biotech
boston top stories
national top stories
new york blog main
san francisco blog main
cancer drugs
ipo
san francisco top stories
sanofi
fda
new york top stories
startups
third rock ventures
boston
deals
europe blog main
general atlantic
investing
new york
revolution medicines
san francisco
takeda pharmaceutical
the column group
venture capital
warp drive bio
abbvie
adeno-associated virus
agios pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
What
medicines
8
×
ipo
cancer
new
research
drug
helped
pipeline
proteins
revolution
targets
therapeutics
years
acquisitions
adding
ago
aim
aiming
announced
balance
based
begin
bio
biosciences
biotech
bio’s
black
boost
brings
bubbles
build
cancer’s
cells
ceo
change
class
clinic
clinical
codiak
collabs
Language
unset
Current search:
cancer
×
medicines
×
" clinical trials "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care